Our program aims to alleviate the tremendous personal, familial, and societal burden of mental illness and substance use disorders by using state-of-the-art technologies to identify molecular markers that can be used to develop new medications and tailor treatment to individual patients.
Our research is guided by the ultimate aim of reducing the tremendous human suffering wrought by psychiatric and substance use disorders.
We capitalize on the rapid advances in genomic technologies that are revolutionizing biomedical research and will profoundly influence health care in the next decade.
We operate from a strong multidisciplinary perspective, blending advanced laboratory, computational, biological, pharmacological and statistical expertise.
Since its inception in 2006, our program has been awarded more than $23 million in research funding from mainly the National Institutes of Health.
We consider biomarkers critical to better understand what is causing disease, find new treatments, and improve disease management.
As developing a new drug takes many years, has a high risk of failure, and costs billions, we also focus on precision medicine that aims to improve treatment by tailor existing medications to individual patients.
Founded the ’Center for Biomarker Research & Precision Medicine’ (BPM) at Virginia Commonwealth University in 2006.
Associate Director and Associate Professor
Dr. Robin F Chan was awarded a prestigious 2019 NARSAD Young Investigator Grant (Brain & Behavior Research Foundation) Read More
Dr. Robin F Chan was awarded a Local SMRT Grant (Pacific Biosciences)Read More
Currently, considerable effort is devoted to finding novel drug targets. Problematically, the development of new medications is extremely expensive and takes many years.Read More
To better understand childhood trauma (e.g., witnessing violent events, abuse or neglect) we capitalized on a study that started at Duke University about 25 years ago…Read More
The methylation of certain regions in our genome tends to change as we age. These age-sensitive methylation sites can be used to estimate someone’s biological age.Read More